Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control…
16 analysts rate HSIC Buy on consensus.
Consensus price target: $96.87 (+12.64% upside from $86.00)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| DANIEL WILLIAM K director | May 11, 2026 | Purchase | 10,000 | $691.9K |
| Popeck Thomas C CEO, Henry Schein Products | Mar 19, 2026 | Sale | 1,355 | $98.63K |
| KUEHN KURT P director | Mar 10, 2026 | Sale | 2,844 | $224.57K |
| LASKAWY PHILIP A director | Mar 5, 2026 | Sale | 2,844 | $228.54K |
| MLOTEK MARK E EVP, Chief Strategic Officer | Mar 4, 2026 | Sale | 1,825 | $147.48K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $13.18B | +4.03% | $398M |
| 2024 | $12.67B | 0% | $390M |
| 2024 | $12.67B | +2.71% | $390M |
Stock data for HSIC: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics